Mabuchi et al., 1989 - Google Patents
The effect of renal transplantation on a major endogenous ligand retained in uremic serumMabuchi et al., 1989
- Document ID
- 5265765001916000888
- Author
- Mabuchi H
- Nakahashi H
- Hamajima T
- Aikawa I
- Oka T
- Publication year
- Publication venue
- American Journal of Kidney Diseases
External Links
Snippet
The effects of renal transplantation on serum concentrations of 3-carboxy-4-methyl-5-propyl- 2-furanpropanoic acid (CMPF) and indole-3-acetic acid (IAA), which are endogenous ligands retained in uremic serum, and on phenytoin binding to serum protein were …
- 210000002966 Serum 0 title abstract description 55
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nussberger et al. | True versus immunoreactive angiotensin II in human plasma. | |
Mogensen et al. | Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids | |
Vanholder et al. | Drug protein binding in chronic renal failure: evaluation of nine drugs | |
Wolkoff et al. | Identification, purification, and partial characterization of an organic anion binding protein from rat liver cell plasma membrane | |
Gupta et al. | Testosterone and its binding in the plasma of male subjects with chronic renal failure | |
Mabuchi et al. | Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia | |
Levitt et al. | Amitriptyline plasma protein binding: effect of plasma pH and relevance to clinical overdose | |
Depner | Suppression of tubular anion transport by an inhibitor of serum protein binding in uremia | |
Sölling | Polymeric forms of free light chains in serum from normal individuals and from patients with renal diseases | |
Mabuchi et al. | A major inhibitor of phenytoin binding to serum protein in uremia | |
Roxin et al. | Radioimmunoassays of human myoglobin in serum and urine | |
Lewis et al. | Hypercupremia associated with a monoclonal immunoglobulin | |
Mabuchi et al. | The effect of renal transplantation on a major endogenous ligand retained in uremic serum | |
Elfström | Plasma protein binding of Phenytoin after cholecystectomy and neurosurgical operations | |
Belpaire et al. | α1‐acid glycoprotein and serum binding of drugs in healthy and diseased dogs | |
Storstein | Studies on digitalis; I. Renal excretion of digitoxin and its cardioactive metabolites | |
Fournier et al. | Evidence that free gamma carboxyglutamic acid circulates in serum | |
Christensen et al. | The binding of thiopental to serum proteins determined by ultrafiltration and equilibrium dialysis | |
Bloom et al. | Urinary porphyrin excretion in normal children and adults | |
Berndt | Probenecid binding by renal cortical slices and homogenates. | |
Gandhi et al. | Importance of charge on transvascular albumin transport in skin and skeletal muscle | |
Tan et al. | Determination of coumarin and umbelliferone mixtures in whole blood by spectrophotofluorometry | |
Groth et al. | Myoglobin kinetics in patients suffering from acute myocardial infarction in its early phase—as studied by the single injection method | |
JPH09501496A (en) | Determination of Carbohydrate Deficient Transferrin by HPLC in Determination of High Alcohol Intake | |
Gomo et al. | High-density lipoprotein apolipoproteins in urine: I. Characterization in normal subjects and in patients with proteinuria. |